Affordable Access

Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer.

Authors
Type
Published Article
Journal
Gynecologic oncology
Publication Date
Volume
96
Issue
3
Pages
902–905
Identifiers
PMID: 15721449
Source
Medline
License
Unknown

Abstract

Bevacizumab has activity in epithelial ovarian carcinoma and larger scale trials are indicated.

Statistics

Seen <100 times